VEGF blockers and ICAM-1/CD18 inhibitors reduce leukocyte adhesion and endothelial dysfunction, alleviating microvascular occlusion (Li, Zhao and Sun 2024a, b, c, d; Reddy et al. 2024). Here, ICAM1 is linked to endothelial dysfunction.